As of April 16, 2025, Kronos Bio (KRON) has a market cap of $52.921 million USD. According to our data, Kronos Bio is ranked No.8026 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $52.92 M |
-7.68%
|
Dec 31, 2024 | $57.32 M |
-24.00%
|
Dec 29, 2023 | $75.43 M |
-22.84%
|
Dec 30, 2022 | $97.75 M |
-88.08%
|
Dec 31, 2021 | $0.82 B |
-54.50%
|
Dec 31, 2020 | $1.80 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.12 B |
0.000 M
|
![]() USA
|
![]() Incyte
INCY
|
$11.31 B |
0.000 M
|
![]() USA
|
![]() Alkermes
ALKS
|
$4.61 B |
-0.000 M
|
![]() Ireland
|
![]() Exelixis
EXEL
|
$10.23 B |
0.000 M
|
![]() USA
|
![]() Blueprint Medicines
BPMC
|
$5.21 B |
0.000 M
|
![]() USA
|
![]() Agios Pharmaceuticals
AGIO
|
$1.59 B |
0.000 M
|
![]() USA
|
![]() MacroGenics
MGNX
|
$79.49 M |
-0.000 M
|
![]() USA
|
![]() Fate Therapeutics
FATE
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() Relay Therapeutics
RLAY
|
$0.47 B |
-0.000 M
|
![]() USA
|
Market Cap | = | KRON Stock Price | * | KRON Shares Outstanding |
= | $0.87 | * | 60.97 M | |
= | $52.92 M |